Subscribe To
Catalyst pharmaceuticals: stable upside potential amid patent infringement concerns
Catalyst's rights acquisition of FYCOMPA is a significant step towards controlling the epilepsy treatment market share. The company's cash balance of ...
February 1, 2023, 1:54 am
Correction — bellicum reports inducement grants under nasdaq listing rule 5635(c)(4)
HOUSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) — In a release issued earlier today by Bellicum pharmaceutical...
January 31, 2023, 11:43 pm
Pfizer can't catch a break, but investors can
Shares of Pfizer Inc. ( PFE , Financial) fell 15% in the month of January, ending the month on a low note with an earnings report that included a lack...
January 31, 2023, 6:10 pm
Medexus schedules third fiscal quarter 2023 conference call
TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Medexus pharmaceuticals (Medexus) (TSX: MDP) (O...
January 31, 2023, 5:00 pm
Pfizer inc. (pfe) q4 2022 earnings call transcript
Pfizer Inc. (NYSE:PFE ) Q4 2022 Results Conference Call January 31, 2023 10:00 AM ET Company Participants Chris Stevo - SVP and Chief IR Officer Dr. A...
January 31, 2023, 4:19 pm
Regeneron announces investor conference presentations
TARRYTON, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Regeneron pharmaceuticals, Inc. (NASDAQ: REGN) will w...
January 31, 2023, 4:01 pm
Checking in with merck stock before earnings
pharmaceutical company Merck & Co (NYSE:MRK) is one of the many big names set to announce its quarterl...
January 31, 2023, 3:03 pm
What makes x4 pharmaceuticals (xfor) a new buy stock
X4 pharmaceuticals (XFOR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...
January 31, 2023, 1:16 pm
Industrial vacuum cleaner market projected to hit usd 800 million by 2025, at a 5% cagr – report by market research future (mrfr)
Industrial Vacuum Cleaner Market Research Report: Information by Product Type (Upright, Canister, Backpack), Mode of Operation (Electric and Pneumatic...
January 31, 2023, 12:25 pm
Pfizer posts record-breaking 2022 full-year revenue of $100b but expects that to fall by 33% in 2023
Pfizer Inc (NYSE:PFE) posted record-high revenue of $100.3 billion in 2022, fueled by more than $50 billion in sales of its Covid-19 vaccine and treat...
January 31, 2023, 11:20 am
Sanofi layoffs 2023: what to know about the latest sny job cuts
The layoff trend has carried into 2023, and it isn't confined to the tech sector. French pharmaceutical...
January 31, 2023, 11:04 am
Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022
The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high....
January 31, 2023, 8:02 am
Aptinyx to present at the svb securities global biopharma conference
EVANSTON, Ill.--( BUSINESS WIRE )--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical comp...
January 31, 2023, 7:47 am
Novabay pharmaceuticals to present at the virtual sequire biotechnology conference on february 2, 2023
EMERYVILLE, Calif.--( BUSINESS WIRE )--NovaBay® pharmaceuticals, Inc. (NYSE American: NBY) announces t...
January 31, 2023, 6:50 am
Quarterly activities and cashflow report
ADELAIDE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO,), (Bionomics or the Company) a clinical-stage bio<...
January 30, 2023, 11:23 pm
Gsk: a defensive with a healthy dividend yield
pharmaceuticals company GSK has seen a nice run up in price in Q4 2022. But with a rotation in favour o...
January 30, 2023, 8:00 pm
Biomarin: opportunity to score home run with latest regulatory advancements
BioMarin pharmaceutical Inc. revenues for Q3 of 2022 came in at $505.3 million, which was a year-over-y...
January 30, 2023, 6:53 pm
Catalyst pharmaceuticals: the firdapse complexity does not end
Catalyst pharmaceuticals, Inc. has been hit with an ANDA notice from Teva ...
January 30, 2023, 6:21 pm
Royalty pharma: uncorrelated yield from pharmaceutical product in uncertain times
Royalty Pharma plc is an interesting investment fund that buys pharmaceutical royalties and generates a...
January 30, 2023, 3:19 pm
Xeris biopharma sees fda grant orphan-drug exclusivity to recorlev for treatment of cushing's syndrome
Xeris Biopharma Holdings (NASDAQ:XERS) Inc revealed that the Food and Drug Administration (FDA) granted its subsidiary Xeris ...
January 30, 2023, 3:04 pm